US Broker Ratings

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: A Biotech Gem with a 72% Upside Potential

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a Massachusetts-based biopharmaceutical company, is garnering attention in the biotechnology sector thanks to its promising pipeline and strong analyst endorsements. With a market capitalization of..

Enhabit, Inc. (EHAB) Investor Outlook: Navigating the Challenges with a Focus on Growth Potential

Investors eyeing the healthcare sector should consider the dynamics of Enhabit, Inc. (NASDAQ: EHAB), a company that stands at the intersection of home health and hospice services in the United..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: A Potential 48.55% Upside in the Biotech Space

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a promising player in the biotechnology sector, is capturing investor attention with a compelling forecasted upside of 48.55%. With a market capitalization of $4.55 billion,..

Bicara Therapeutics Inc. (BCAX) Investor Outlook: A Promising 42% Upside in Biotechnology

Bicara Therapeutics Inc. (NASDAQ: BCAX) is capturing investor attention with its robust market potential and promising outlook in the biotechnology sector. With a market capitalization of $1.41 billion, this U.S.-based..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: A Robust Revenue Growth Story with Promising Investment Potential

Theravance Biopharma, Inc. (NASDAQ: TBPH) stands out in the biotechnology sector with its impressive revenue growth and strategic partnerships. Based in South San Francisco, California, this biopharmaceutical company is committed..

Eton Pharmaceuticals Inc. (ETON) Stock Analysis: Unveiling a Promising 57.40% Upside Potential

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company based in Deer Park, Illinois, has been making waves in the healthcare sector with its focus on developing treatments for rare..

RxSight, Inc. (RXST) Investor Outlook: Exploring the 53.83% Potential Upside in the Medical Device Sector

RxSight, Inc. (NASDAQ: RXST) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Aliso Viejo, California, the company focuses on the development and..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Exploring a 47% Potential Upside Amid Clinical Advancements

Arcus Biosciences, Inc. (NASDAQ: RCUS) is capturing the attention of investors with its promising pipeline of cancer therapies and a compelling potential upside of 47.21%, as suggested by analyst target..

AnaptysBio (ANAB) Stock Analysis: Unpacking the 38% Potential Upside in Biotechnology

AnaptysBio, Inc. (NASDAQ: ANAB) is capturing investor attention with an impressive potential upside of 38.22%, as suggested by its average target price. As a clinical-stage biotechnology company, AnaptysBio is at..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Is a 46.89% Upside Within Reach?

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) presents a compelling opportunity in the healthcare sector, particularly within the dynamic biotechnology industry. With a market capitalization of $1.08 billion, Maravai’s presence in..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Unpacking a 210% Potential Upside in the Biotech Sector

For investors eyeing opportunities in the healthcare sector, Niagen Bioscience, Inc. (NASDAQ: NAGE) presents a compelling case with a significant 210.50% potential upside, according to recent analyst ratings. As a..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a 226% Potential Upside in the Biotech Space

REGENXBIO Inc. (NASDAQ: RGNX) is a name making waves in the biotechnology sector with its innovative approach to tackling genetic disorders through gene therapy. As a clinical-stage biotech firm, REGENXBIO..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: A Biotechnology Pioneer with a 36% Upside Potential

Relay Therapeutics, Inc. (NASDAQ: RLAY) stands out in the biotechnology sector as a clinical-stage precision medicines company focusing on advancing small molecule therapeutic discovery in targeted oncology and genetic disease..

Evolus, Inc. (EOLS) Stock Analysis: Exploring a 263.94% Potential Upside in the Healthcare Sector

Evolus, Inc. (NASDAQ: EOLS), a prominent player in the healthcare sector, is drawing significant attention from investors with its potential upside of 263.94%. As a company specialized in the delivery..

Valneva SE (VALN) Stock Analysis: Exploring a Potential 119% Upside Amid Vaccine Innovations

Valneva SE (NASDAQ: VALN), a French biotechnology company specializing in prophylactic vaccines, is capturing the attention of investors due to its significant potential upside of 119.26%, as indicated by analyst..

Nurix Therapeutics, Inc. (NRIX): Analyst Ratings Signal a Potential 93% Upside for Biotech Innovator

For investors eyeing the biotechnology sector, Nurix Therapeutics, Inc. (NASDAQ: NRIX) presents an intriguing opportunity. This clinical-stage biopharmaceutical firm, headquartered in Brisbane, California, is pioneering advancements in cancer and inflammatory..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Exploring a 162% Potential Upside

Gyre Therapeutics, Inc. (NASDAQ: GYRE), a prominent player in the biotechnology sector, is currently turning heads with its impressive potential upside of 162.17%, according to recent analyst ratings. With a..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating Challenges with a Steady Growth in Revenue

InnovAge Holding Corp. (NASDAQ: INNV), a prominent player in the healthcare sector, particularly within the medical care facilities industry, has been making headlines with its innovative approach to senior care...

Xencor, Inc. (XNCR) Stock Analysis: Navigating a 121.83% Potential Upside in the Biotech Sector

Xencor, Inc. (XNCR), a prominent player in the biotechnology industry, stands out with its promising potential upside of 121.83%, making it a stock worth considering for individual investors seeking exposure..

HealthStream, Inc. (HSTM) Stock Analysis: Navigating Potential 49% Upside in the Healthcare SaaS Market

HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the Health Information Services industry, is drawing attention from investors with its strategic position in the burgeoning Software-as-a-Service (SaaS) sector tailored for..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds